A systematic review on the definition of rhabdomyolysis.
Clinical symptoms
Definition
Rhabdomyolysis
Serum creatine kinase (sCK)
Systematic review
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
07
12
2018
accepted:
03
01
2019
revised:
03
01
2019
pubmed:
9
1
2019
medline:
2
1
2021
entrez:
9
1
2019
Statut:
ppublish
Résumé
Rhabdomyolysis (RML) is an interdisciplinary condition due to muscle cell injury followed by the release of cell components into circulation. Etiology of RML has a broad range; a serious complication is acute kidney injury (AKI). Despite its high relevance, there is no established formal definition for RML. A systematic review, focusing on RML definition, providing a recommendation for clinicians. Systematic literature research in PubMed and Embase (1968-07/2018). The database research presented 8136 articles in PubMed and 2151 in Embase. After screening, 614 papers were retained for statistical analysis. A retrospective study was the most used design (44%). A definition of RML was stated in 231 studies (37.6%), including a precise creatine kinase level (CK) cut-off most frequently (67.1%). In 53/231 (22.9%) studies the CK cut-off was > 5 × upper limit of normal (ULN), and in 64/231 (27.7%) studies > 1000 IU/L. Further components of definitions were elevated CK without specific thresholds, and clinical symptoms. Exclusion criteria referring to the definition of RML were established in 113 studies, including myocardial, renal, cerebral and neuromuscular characteristics. At present, we recommend a clinical syndrome of acute muscle weakness, myalgia, and muscle swelling combined with a CK cut-off value of > 1000 IU/L/ or CK > 5 × ULN for the standard definition of a mild RML. Additionally measured myoglobinuria and AKI indicate a severe type of RML. Exclusion criteria as well as the chronological sequence need to be considered for a conclusive RML definition.
Sections du résumé
BACKGROUND
BACKGROUND
Rhabdomyolysis (RML) is an interdisciplinary condition due to muscle cell injury followed by the release of cell components into circulation. Etiology of RML has a broad range; a serious complication is acute kidney injury (AKI). Despite its high relevance, there is no established formal definition for RML.
OBJECTIVES
OBJECTIVE
A systematic review, focusing on RML definition, providing a recommendation for clinicians.
METHOD
METHODS
Systematic literature research in PubMed and Embase (1968-07/2018).
RESULTS
RESULTS
The database research presented 8136 articles in PubMed and 2151 in Embase. After screening, 614 papers were retained for statistical analysis. A retrospective study was the most used design (44%). A definition of RML was stated in 231 studies (37.6%), including a precise creatine kinase level (CK) cut-off most frequently (67.1%). In 53/231 (22.9%) studies the CK cut-off was > 5 × upper limit of normal (ULN), and in 64/231 (27.7%) studies > 1000 IU/L. Further components of definitions were elevated CK without specific thresholds, and clinical symptoms. Exclusion criteria referring to the definition of RML were established in 113 studies, including myocardial, renal, cerebral and neuromuscular characteristics.
CONCLUSION
CONCLUSIONS
At present, we recommend a clinical syndrome of acute muscle weakness, myalgia, and muscle swelling combined with a CK cut-off value of > 1000 IU/L/ or CK > 5 × ULN for the standard definition of a mild RML. Additionally measured myoglobinuria and AKI indicate a severe type of RML. Exclusion criteria as well as the chronological sequence need to be considered for a conclusive RML definition.
Identifiants
pubmed: 30617905
doi: 10.1007/s00415-019-09185-4
pii: 10.1007/s00415-019-09185-4
doi:
Substances chimiques
Creatine Kinase
EC 2.7.3.2
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
877-882Références
J Am Geriatr Soc. 1992 May;40(5):454-6
pubmed: 1634696
N Engl J Med. 1996 Apr 25;334(17):1100-4
pubmed: 8598869
Am J Case Rep. 2016 Nov 30;17:905-908
pubmed: 27899787
N Engl J Med. 2009 Jul 2;361(1):62-72
pubmed: 19571284
Case Rep Nephrol. 2017;2017:8596981
pubmed: 28706746
Br Med J. 1941 Mar 22;1(4185):427-32
pubmed: 20783577
J Am Soc Nephrol. 2000 Aug;11(8):1553-61
pubmed: 10906171
Orphanet J Rare Dis. 2015 May 02;10:51
pubmed: 25929793
Pediatr Nephrol. 2008 Dec;23(12):2281-4
pubmed: 18607638
Neuromuscul Disord. 2014 Aug;24(8):651-9
pubmed: 24946698
J Prim Health Care. 2017 Dec;9(4):316-320
pubmed: 29530144
Vojnosanit Pregl. 2013 Nov;70(11):1039-45
pubmed: 24397200
CMAJ Open. 2015 Jan 13;3(1):E83-90
pubmed: 25844375
Am J Nephrol. 1997;17(3-4):392-4
pubmed: 9189260
J Inherit Metab Dis. 2012 Nov;35(6):1119-28
pubmed: 22481384
Crit Care. 2016 Jun 15;20(1):135
pubmed: 27301374
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Medicine (Baltimore). 1982 May;61(3):141-52
pubmed: 7078398
N Engl J Med. 1991 May 16;324(20):1417-22
pubmed: 2020298
Muscle Nerve. 2002 Mar;25(3):332-47
pubmed: 11870710
Pediatr Gastroenterol Hepatol Nutr. 2017 Jun;20(2):124-129
pubmed: 28730137
Am J Cardiovasc Drugs. 2010;10(3):187-92
pubmed: 20524720
Eur J Intern Med. 2008 Dec;19(8):568-74
pubmed: 19046720
Crit Care. 2007;11(2):R31
pubmed: 17331245
Ochsner J. 2015 Spring;15(1):58-69
pubmed: 25829882
Pediatrics. 2006 Nov;118(5):2119-25
pubmed: 17079586
Intern Emerg Med. 2007 Oct;2(3):210-8
pubmed: 17909702
BMC Neurol. 2017 Sep 19;17(1):187
pubmed: 28927394
Diabetes Res Clin Pract. 1994 Dec 31;26(3):209-14
pubmed: 7736901
Crit Care. 2005 Apr;9(2):158-69
pubmed: 15774072